Literature DB >> 10802658

Protection of Rpe65-deficient mice identifies rhodopsin as a mediator of light-induced retinal degeneration.

C Grimm1, A Wenzel, F Hafezi, S Yu, T M Redmond, C E Remé.   

Abstract

Light-induced apoptosis of photoreceptors represents an animal model for retinal degeneration. Major human diseases that affect vision, such as age-related macular degeneration (AMD) and some forms of retinitis pigmentosa (RP), may be promoted by light. The receptor mediating light damage, however, has not yet been conclusively identified; candidate molecules include prostaglandin synthase, cytochrome oxidase, rhodopsin, and opsins of the cones and the retinal pigment epithelium (PE). We exposed to bright light two groups of genetically altered mice that lack the visual pigment rhodopsin (Rpe65-/- and Rho-/-). The gene Rpe65 is specifically expressed in the PE and essential for the re-isomerization of all-trans retinol in the visual cycle and thus for the regeneration of rhodopsin after bleaching. Rho-/- mice do not express the apoprotein opsin in photoreceptors, which, consequently, do not contain rhodopsin. We show that photoreceptors lacking rhodopsin in these mice are completely protected against light-induced apoptosis. The transcription factor AP-1, a central element in the apoptotic response to light, is not activated in the absence of rhodopsin, indicating that rhodopsin is essential for the generation or transduction of the intracellular death signal induced by light.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10802658     DOI: 10.1038/75614

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  96 in total

Review 1.  Why study rod cell death in retinal degenerations and how?

Authors:  C E Remé; C Grimm; F Hafezi; H P Iseli; A Wenzel
Journal:  Doc Ophthalmol       Date:  2003-01       Impact factor: 2.379

Review 2.  DNA repair in photoreceptor survival.

Authors:  M Soledad Cortina; William C Gordon; Walter J Lukiw; Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2003-10       Impact factor: 5.590

3.  How much blue light should an IOL transmit?

Authors:  M A Mainster; J R Sparrow
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

Review 4.  Light damage to the retina: an historical approach.

Authors:  D van Norren; J J Vos
Journal:  Eye (Lond)       Date:  2015-11-06       Impact factor: 3.775

Review 5.  Photoreceptor cell death and rescue in retinal detachment and degenerations.

Authors:  Yusuke Murakami; Shoji Notomi; Toshio Hisatomi; Toru Nakazawa; Tatsuro Ishibashi; Joan W Miller; Demetrios G Vavvas
Journal:  Prog Retin Eye Res       Date:  2013-08-28       Impact factor: 21.198

Review 6.  Light and inherited retinal degeneration.

Authors:  D M Paskowitz; M M LaVail; J L Duncan
Journal:  Br J Ophthalmol       Date:  2006-05-17       Impact factor: 4.638

7.  Redox proteomic identification of visual arrestin dimerization in photoreceptor degeneration after photic injury.

Authors:  Christopher J Lieven; Jonathan D Ribich; Megan E Crowe; Leonard A Levin
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-26       Impact factor: 4.799

8.  Systems pharmacology identifies drug targets for Stargardt disease-associated retinal degeneration.

Authors:  Yu Chen; Grazyna Palczewska; Debarshi Mustafi; Marcin Golczak; Zhiqian Dong; Osamu Sawada; Tadao Maeda; Akiko Maeda; Krzysztof Palczewski
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 14.808

9.  Early alterations in mitochondrial reserve capacity; a means to predict subsequent photoreceptor cell death.

Authors:  Nathan R Perron; Craig Beeson; Bärbel Rohrer
Journal:  J Bioenerg Biomembr       Date:  2012-10-23       Impact factor: 2.945

10.  Effect of g protein-coupled receptor kinase 1 (Grk1) overexpression on rod photoreceptor cell viability.

Authors:  Tiffany Whitcomb; Keisuke Sakurai; Bruce M Brown; Joyce E Young; Lowell Sheflin; Cynthia Dlugos; Cheryl M Craft; Vladimir J Kefalov; Shahrokh C Khani
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-15       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.